All In Biotech

Investigational drug · Phase 3

PCV21 vaccine

Not approved by FDA. In 5 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Pneumococcal Immunization, Healthy Volunteers.

Phase 3

Last checked: Nov 20, 2026Latest source record: Oct 5, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

5

5 still active

All registered trials

13

Any phase or sponsor naming "PCV21 vaccine"

First trial start

2024

Dec 18, 2024

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "PCV21 vaccine", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Pneumococcal Immunization
  • Healthy Volunteers

Largest trials

Live from ClinicalTrials.gov: studies naming "PCV21 vaccine" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 4 on PubMed

Also in development for Pneumococcal Immunization

  • DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials

    Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization

  • M-M-R II vaccinePhase 33 trials

    Sanofi · Pneumococcal Immunization

  • HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials

    Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Sanofi.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.